Published in Comput Aided Surg on September 01, 2008
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology (2010) 2.38
D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol (2011) 2.10
Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol (2011) 2.03
Imaging techniques for prostate cancer: implications for focal therapy. Nat Rev Urol (2009) 1.76
Elastic registration of multimodal prostate MRI and histology via multiattribute combined mutual information. Med Phys (2011) 1.54
Image registration for targeted MRI-guided transperineal prostate biopsy. J Magn Reson Imaging (2012) 1.50
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int (2012) 1.42
Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours. Eur Radiol (2011) 1.29
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology (2012) 1.28
Documenting the location of prostate biopsies with image fusion. BJU Int (2011) 1.23
Multimodality image fusion-guided procedures: technique, accuracy, and applications. Cardiovasc Intervent Radiol (2012) 1.18
Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. Radiology (2015) 1.16
Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Eur Radiol (2010) 1.12
Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy. Urol Oncol (2013) 1.02
Applications of transrectal ultrasound in prostate cancer. Br J Radiol (2012) 0.95
Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective. NMR Biomed (2013) 0.92
MRI-Safe Robot for Endorectal Prostate Biopsy. IEEE ASME Trans Mechatron (2013) 0.90
Logistic regression model for diagnosis of transition zone prostate cancer on multi-parametric MRI. Eur Radiol (2014) 0.90
Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications. Acad Radiol (2016) 0.89
Image-guided robotic interventions for prostate cancer. Nat Rev Urol (2013) 0.89
Accelerated T2 mapping for characterization of prostate cancer. Magn Reson Med (2011) 0.89
Robotic ultrasound and needle guidance for prostate cancer management: review of the contemporary literature. Curr Opin Urol (2014) 0.88
Automated prostate cancer detection using T2-weighted and high-b-value diffusion-weighted magnetic resonance imaging. Med Phys (2015) 0.88
Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes. Curr Urol Rep (2016) 0.86
Fully Automated Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Fusion via a Probabilistic Registration Metric. Proc SPIE Int Soc Opt Eng (2013) 0.85
Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI. Cancer Imaging (2011) 0.83
Image guidance for focal therapy of prostate cancer. World J Urol (2010) 0.83
Screening and detection advances in magnetic resonance image-guided prostate biopsy. Urol Clin North Am (2014) 0.83
Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy. J Urol (2016) 0.83
"Textural analysis of multiparametric MRI detects transition zone prostate cancer". Eur Radiol (2016) 0.82
Image fusion during vascular and nonvascular image-guided procedures. Tech Vasc Interv Radiol (2013) 0.82
Augmenting MRI-transrectal ultrasound-guided prostate biopsy with temporal ultrasound data: a clinical feasibility study. Int J Comput Assist Radiol Surg (2015) 0.81
Computer aided-diagnosis of prostate cancer on multiparametric MRI: a technical review of current research. Biomed Res Int (2014) 0.80
Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session. Diagn Interv Radiol (2014) 0.79
Multiattribute probabilistic prostate elastic registration (MAPPER): application to fusion of ultrasound and magnetic resonance imaging. Med Phys (2015) 0.79
Real-time co-registration using novel ultrasound technology: ex vivo validation and in vivo applications. J Am Soc Echocardiogr (2011) 0.79
Tissue mimicking materials for the detection of prostate cancer using shear wave elastography: a validation study. Med Phys (2013) 0.79
Population-based prediction of subject-specific prostate deformation for MR-to-ultrasound image registration. Med Image Anal (2015) 0.79
Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology. Urology (2015) 0.78
Multiparametric MRI-targeted TRUS prostate biopsies using visual registration. Biomed Res Int (2014) 0.77
Is visual registration equivalent to semiautomated registration in prostate biopsy? Biomed Res Int (2015) 0.76
Navigational Tools for Interventional Radiology and Interventional Oncology Applications. Semin Intervent Radiol (2015) 0.75
Development and Phantom Validation of a 3D-Ultrasound-Guided System for Targeting MRI-visible Lesions during Transrectal Prostate Biopsy. IEEE Trans Biomed Eng (2016) 0.75
Accuracy of Elastic Fusion of Prostate Magnetic Resonance and Transrectal Ultrasound Images under Routine Conditions: A Prospective Multi-Operator Study. PLoS One (2016) 0.75
2D Ultrasound and 3D MR Image Registration of the Prostate for Brachytherapy Surgical Navigation. Medicine (Baltimore) (2015) 0.75
Non-rigid MR-TRUS image registration for image-guided prostate biopsy using correlation ratio-based mutual information. Biomed Eng Online (2017) 0.75
Color-coded visualization of magnetic resonance imaging multiparametric maps. Sci Rep (2017) 0.75
Prostate biopsy for the interventional radiologist. J Vasc Interv Radiol (2014) 0.75
Magnetic-resonance-guided biopsy of focal liver lesions. Pediatr Radiol (2017) 0.75
Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning. Curr Urol Rep (2017) 0.75
Ultrasound-guided genitourinary interventions: principles and techniques. Ultrasonography (2017) 0.75
Learning Non-rigid Deformations for Robust, Constrained Point-based Registration in Image-Guided MR-TRUS Prostate Intervention. Med Image Anal (2017) 0.75
Detection and grading of prostate cancer using temporal enhanced ultrasound: combining deep neural networks and tissue mimicking simulations. Int J Comput Assist Radiol Surg (2017) 0.75
Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI. Eur J Radiol Open (2017) 0.75
HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans Med Imaging (2002) 12.71
Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol (2007) 2.92
Real time MRI-ultrasound image guided stereotactic prostate biopsy. Magn Reson Imaging (2002) 2.69
Closed-loop control in fused MR-TRUS image-guided prostate biopsy. Med Image Comput Comput Assist Interv (2007) 1.95
Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol (1998) 1.88
Image fusion of MR images and real-time ultrasonography: evaluation of fusion accuracy combining two commercial instruments, a neuronavigation system and a ultrasound system. Acta Neurochir (Wien) (2003) 1.77
Three-dimensional imaging with stereotactic ultrasonography. Comput Med Imaging Graph (1994) 1.66
Respiratory-induced prostate motion: quantification and characterization. Int J Radiat Oncol Biol Phys (2000) 1.66
Towards 3D ultrasound image based soft tissue tracking: a transrectal ultrasound prostate image alignment system. Med Image Comput Comput Assist Interv (2007) 1.02
ESUR prostate MR guidelines 2012. Eur Radiol (2012) 8.86
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med (2011) 5.15
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell (2002) 5.10
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol (2013) 4.64
Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol (2006) 3.53
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol (2013) 3.34
Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomarkers Prev (2002) 3.12
Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet (2003) 2.88
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol (2013) 2.81
Navigation with electromagnetic tracking for interventional radiology procedures: a feasibility study. J Vasc Interv Radiol (2005) 2.67
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol (2013) 2.62
Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol (2012) 2.59
Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol (2012) 2.55
Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology (2003) 2.53
11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med (2012) 2.42
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology (2010) 2.38
Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology (2013) 2.35
Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease. Gastroenterology (2012) 2.33
Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. J Urol (2005) 2.33
Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 2.29
Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer. Cancer (2014) 2.27
Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst (2008) 2.25
Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome. Am J Respir Crit Care Med (2007) 2.19
Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res (2007) 2.17
D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol (2011) 2.10
Effects of perfusion on radiofrequency ablation in swine kidneys. Radiology (2004) 2.07
Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. J Vasc Interv Radiol (2007) 2.00
Cediranib for metastatic alveolar soft part sarcoma. J Clin Oncol (2013) 1.99
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer (2013) 1.97
Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner. J Urol (2006) 1.96
Closed-loop control in fused MR-TRUS image-guided prostate biopsy. Med Image Comput Comput Assist Interv (2007) 1.95
Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology (2009) 1.95
The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2003) 1.93
Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics (2004) 1.92
Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol (2007) 1.92
Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol (2007) 1.86
Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int (2007) 1.86
Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience. Diabetes Care (2003) 1.86
The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol (2007) 1.84
Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. Radiology (2008) 1.82
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78
Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location. Hum Mutat (2004) 1.78
Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol (2002) 1.74
Solitary cysticercosis in the intermuscular area of the thigh: a rare and unusual pseudotumor with characteristic imaging findings. J Comput Assist Tomogr (2005) 1.73
System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner. Magn Reson Med (2004) 1.71
Lymph node control in cervical cancer. Int J Radiat Oncol Biol Phys (2004) 1.70
Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics. Clin Cancer Res (2007) 1.64
A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy. Ann Surg Oncol (2004) 1.56
Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model. Radiology (2006) 1.51
Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla. BJU Int (2012) 1.51
Percutaneous ablation in the kidney. Radiology (2011) 1.51
Comparison of robotic versus laparoscopic skills: is there a difference in the learning curve? Urology (2002) 1.50
Endovascular management of life-threatening retroperitoneal bleeding. ANZ J Surg (2008) 1.50
Challenges in clinical prostate cancer: role of imaging. AJR Am J Roentgenol (2009) 1.49
Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J Control Release (2011) 1.49
Metastatic involvement of a retrieved inferior vena cava filter. J Vasc Interv Radiol (2003) 1.49
The role of pancreatic ductal secretion in protection against acute pancreatitis in mice*. Crit Care Med (2014) 1.46
Percutaneous radiofrequency ablation of chordoma. AJR Am J Roentgenol (2002) 1.45
Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res (2004) 1.45
CT virtual bronchoscopy of the central airways in patients with Wegener's granulomatosis. Chest (2002) 1.45
MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys (2004) 1.44
Clinical utility of real-time fusion guidance for biopsy and ablation. J Vasc Interv Radiol (2011) 1.44
Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future. J Vasc Interv Radiol (2007) 1.43
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int (2012) 1.42
A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds. Rev Sci Instrum (2009) 1.42
Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol (2004) 1.42
Laparoscopic management of ureteropelvic junction obstruction in patients with upper urinary tract anomalies. J Urol (2004) 1.39
Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. Biotechniques (2003) 1.36
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer. Cancer (2007) 1.36
Quantitation of the reconstruction quality of a four-dimensional computed tomography process for lung cancer patients. Med Phys (2005) 1.35
Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med (2012) 1.34